Auris Medical Holding Ltd. logo
Auris Medical Holding Ltd. EARS

Auris Medical Holding Ltd. Revenue 2011-2026 | EARS

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Auris Medical Holding Ltd.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
174 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
174 K 174 K 174 K

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Biotechnology industry

Issuer Revenue Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
238 M - 2.43 % $ 254 M germanyGermany
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
3.71 B $ 311.28 0.91 % $ 40.8 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
1.26 M - 2.71 % $ 14 M usaUSA
argenx SE argenx SE
ARGX
36.4 M $ 849.62 1.93 % $ 25 B niderlandNiderland
Acasti Pharma Acasti Pharma
ACST
100 M - 4.01 % $ 150 M canadaCanada
I-Mab I-Mab
IMAB
88 M - - $ 866 M chinaChina
Adverum Biotechnologies Adverum Biotechnologies
ADVM
1 M - - $ 86.2 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
325 K - - $ 26.5 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
6.07 B - - $ 40.3 B usaUSA
Adagene Adagene
ADAG
10.2 M $ 2.89 1.4 % $ 163 M chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
912 K $ 0.83 -2.66 % $ 4.53 M chinaChina
AlloVir AlloVir
ALVR
165 K - 4.14 % $ 49.1 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
381 K - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 K - -1.52 % $ 24.7 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
1.16 M - -11.43 % $ 502 K usaUSA
Biogen Biogen
BIIB
9.89 B $ 197.99 1.27 % $ 29 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
109 K $ 3.4 -3.11 % $ 8.18 B australiaAustralia
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
48.2 B $ 60.66 1.34 % $ 123 B usaUSA
BioNTech SE BioNTech SE
BNTX
482 M $ 107.08 1.25 % $ 27.2 B germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
118 M - -24.86 % $ 820 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
886 K - - $ 1.01 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
40.6 M - -0.23 % $ 916 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.08 B - - - russiaRussia
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
364 M $ 219.23 0.52 % $ 5 B danmarkDanmark
Aptinyx Aptinyx
APTX
1 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
9.14 M - -13.39 % $ 1.45 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
54 K - -6.81 % $ 3.04 B usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
3.09 M - 17.91 % $ 11.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
9.59 M - 5.93 % $ 314 M canadaCanada
Brickell Biotech Brickell Biotech
BBI
8.01 M - -5.38 % $ 6.06 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
142 K - -10.17 % $ 12.2 K usaUSA
Athersys Athersys
ATHX
5.51 M - 3.77 % $ 22.4 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
675 M $ 39.76 3.7 % $ 4.1 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
3.81 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
242 K $ 1.43 3.62 % $ 365 M britainBritain
Burford Capital Limited Burford Capital Limited
BUR
330 M $ 9.37 0.75 % $ 1.49 B britainBritain
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
2.79 B $ 14.79 1.09 % $ 4.57 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
18.1 M - 1.93 % $ 17.4 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
3.51 M $ 52.55 7.4 % $ 4.73 B schweizSchweiz